Crescita Therapeutics Inc CRRTF
$0.56
Last Updated: May 27, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
CRRTF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Crescita Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Crescita Therapeutics Inc. Stock Analysis CRRTF
United States Health Care Nano Cap Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. The company is headquartered in Laval, Quebec and currently employs 65 full-time employees. The company went IPO on 2016-03-07. The company offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. The company operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. The company also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment is engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. The Manufacturing and Services segment is engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.
Crescita Therapeutics Inc (CRRTF) Chart
Financial Metrics & Statements of Crescita Therapeutics Inc (CRRTF)
FAQ's for Crescita Therapeutics Inc (CRRTF)
- As of August 2026, Crescita Therapeutics Inc CRRTF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Crescita Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Crescita Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Crescita Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Crescita Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Crescita Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Crescita Therapeutics Inc (CRRTF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
